| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.29B | 13.73B | 14.64B | 18.36B | 16.09B | 13.00B |
| Gross Profit | 2.47B | 2.57B | 2.49B | 2.66B | 2.34B | 1.95B |
| EBITDA | 681.00M | 952.00M | 978.00M | 929.00M | 884.00M | 596.00M |
| Net Income | 390.00M | 435.00M | 512.00M | 438.00M | 358.00M | 324.00M |
Balance Sheet | ||||||
| Total Assets | 13.12B | 12.81B | 13.18B | 12.78B | 12.79B | 11.79B |
| Cash, Cash Equivalents and Short-Term Investments | 2.11B | 1.98B | 2.04B | 1.78B | 1.96B | 2.00B |
| Total Debt | 6.03B | 5.26B | 5.90B | 6.47B | 7.00B | 6.49B |
| Total Liabilities | 8.48B | 7.96B | 8.57B | 8.99B | 9.33B | 8.71B |
| Stockholders Equity | 4.64B | 4.85B | 4.61B | 3.79B | 3.46B | 3.08B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 759.00M | 897.00M | 454.00M | -452.00M | 110.00M |
| Operating Cash Flow | 0.00 | 877.00M | 908.00M | 775.00M | 633.00M | 790.00M |
| Investing Cash Flow | 0.00 | -153.00M | 74.00M | -302.00M | -1.06B | 416.00M |
| Financing Cash Flow | 0.00 | -788.00M | -737.00M | -658.00M | 379.00M | -605.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥5.77B | 5.29 | ― | 3.02% | 7.54% | 44.72% | |
71 Outperform | ¥24.04B | 3.25 | ― | 1.29% | 4.21% | 35.32% | |
71 Outperform | ¥2.24B | 6.11 | ― | 3.32% | 7.26% | 55.00% | |
70 Outperform | ¥17.95B | 15.36 | ― | 1.38% | 7.07% | 26.88% | |
65 Neutral | ¥11.47B | 10.98 | ― | 1.87% | -0.35% | 11.44% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥3.72B | 8.39 | ― | 2.93% | 0.09% | -44.81% |